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ABSTRACT
Background: The use of laparoscopy in the treatment of
gastric malignancy is still controversial. However, several
reports suggest that the laparoscopic approach may be
safe and applicable. The aim of this study was to review
our experience with laparoscopic gastrectomy for gastric
malignant tumors amenable to subtotal gastrectomy, and
assess the oncologic outcome.
Methods: The laparoscopic approach to subtotal gastrec-
tomy was selected according to both the surgeon’s and
patient’s preference. Data regarding demographics, oper-
ative procedures, postoperative course, and follow-up
were prospectively collected in a computerized database.
Survival data were obtained from the national census.
Results: Twenty patients were operated on, 18 for gastric
adenocarcinoma, one for gastric lymphoma, and one for
gastrointestinal stromal tumor. There were 10 males and
10 females, mean age of 67. D1 subtotal gastrectomy with
Billroth-2 reconstruction was performed. Mean operative
time was 335 minutes. Tumor-free margins were obtained
in all cases, and a mean of 15 lymph nodes were retrieved.
Median postoperative hospital stay was 12 days. Postop-
erative complications included leak from the duodenal
stump (2), intraabdominal abscess (2), anastomotic leak
(1), wound infection (1), and bowel obstruction (1); re-
operation was required in 4 patients. No perioperative
mortality occurred in our series. Pathology showed nodal
involvement in 8 patients. During a mean follow-up of 39
months, 4 patients expired from recurrent and metastatic
disease; all had positive lymph nodes. The Kaplan-Meier
calculated 5-year survival was 79%.
Conclusion: Although a challenging and lengthy proce-
dure, laparoscopic subtotal gastrectomy yields acceptable
surgical and oncologic results that may further improve
with increased surgeon experience. Thus, the application
of laparoscopy in the surgical treatment of distal gastric
malignancy may be considered; however, further data are
needed before this approach can be recommended.
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INTRODUCTION
Despite the rapid development and application of lapa-
roscopy for a wide variety of pathologies, 2 major factors
continue to limit its widespread use for gastric malig-
nancy: technical complexity requiring advanced laparo-
scopic skills and concerns regarding oncologic safety.
Specifically, the laparoscopic approach involves a length-
ier and more complex procedure with the need for spe-
cialized equipment and a high level of dexterity. Thus,
many surgeons opt for the traditional open technique,
especially when dealing with malignancy, where con-
cerns that the laparoscopic approach may not yield similar
results to those achieved by open surgery, such as the
extent of resection and recurrence. To adopt a radical
change for the preference of laparoscopy over open sur-
gery for gastric malignancy, justification must first be pre-
sented by way of a demonstrated significant advantage.
For these reasons, laparoscopic gastric resection is not
currently widely practiced, and as a result data relative to
its safety and efficacy are limited.
Another limiting factor in reaching any evidence-based
conclusions regarding laparoscopy for gastric malignancy
is the relatively low incidence of this type of cancer in the
Western hemisphere. Conversely, colonic cancer has a
much wider prevalence that has allowed for a plethora of
data establishing the safety of laparoscopic colectomy. In
Japan, for example, where the incidence of gastric cancer
is higher, laparoscopic gastrectomy has been performed
for more than 10 years.1 However, it may be difficult to
extrapolate from the Japanese experience, because more
stringent population screening leads to earlier detection.
In addition, even when diagnosed at an operable stage,
the overall prognosis of gastric cancer is more dismal in
Western countries than in Japan.
Although reported results are limited, based on the prom-
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SCIENTIFIC PAPERising experiences of laparoscopic gastrectomy from sev-
eral European and North American Centers, in 2001 we
started to perform laparoscopic gastrectomy at our insti-
tution. The aim of this study was to review our experience
with laparoscopic subtotal gastrectomy for gastric malig-
nancy, focusing specifically on the perioperative course
and postoperative oncologic results.
METHODS
Patient Selection
All patients diagnosed with resectable gastric malignancy
at the distal stomach between 2001 and 2006 were poten-
tially eligible for laparoscopic gastric resection. Patients
were selected for the laparoscopic approach based on
both the surgeon’s and patient’s preference. Tumor size
was not considered as an exclusion criterion. The final
decision regarding the selected surgical approach was
made by the operating surgeon. The choice of subtotal
gastrectomy was based on the location of the tumor in the
stomach, which allowed sufficient resection margins with
ample residual proximal stomach for the creation of the
gastrojejunal anastomosis.
Data Collection and Analysis
Data regarding patient demographics, type of surgery,
intraoperative and postoperative course, including com-
plications and repeat procedures, pathologic results, ad-
juvant and neoadjuvant therapy, and long-term follow-up,
including late complications, local recurrence, metastatic
spread, and survival were prospectively entered into a
computerized database and retrospectively analyzed.
Early postoperative complications were defined as those
occurring immediately following surgery or within 2
weeks after the procedure. Follow-up data were obtained
from the patient’s routine outpatient clinic visits. National
census data were used to determine survival time.
Operative Technique
Surgery was performed with the patient in the supine
position and the surgeon standing between the patient’s
legs. Abdominal entry was made immediately above the
umbilicus, by the open Hasson technique (for patients
who had prior surgery) or a Veress needle, for initial CO2
insufflation; 4 additional ports were usually necessary to
complete the procedure.
Abdominal exploration was initially performed to rule out
metastatic spread. The tumor location at the stomach was
confirmed visually and by instrumental palpation, to de-
termine the appropriate surgical procedure. Resection
commenced with mobilization of the omentum from its
attachments to the transverse colon, for inclusion in the
surgical specimen. This dissection allows entry into the
lesser sac to examine the posterior gastric wall and rule
out posterior tumoral penetration into the pancreas (Fig-
ure 1). Further dissection was carried out distally, along
the greater curve of the stomach, towards the gastric
outlet; care was taken to avoid the transverse mesocolon
while transecting the right gastroepiploic artery. The first
part of the duodenum was then dissected and transected
using a linear stapler; sutures were usually added to rein-
force the duodenal closure. Proximal dissection along the
greater curvature was then carried out to the proximal
tumor margins, at least 5cm from the tumor. The short
gastric vessels to the spleen were then transected to a
height depending on the level of transection. At this stage,
dissection was continued at the lesser curvature side of
the stomach, with division of the right gastric artery near
the antrum. The left gastric artery is usually divided at its
origin if high transection is required or at its branches if
more proximal stomach is to be retained. Generally, peri-
gastric lymph nodes were removed with the specimen (D1
dissection), and no attempt was made to dissect distant
nodes (D2 dissection), unless evidently enlarged (similar
to our open approach).
After dissection was completed, the stomach was horizon-
tally transected using several cartridges of a linear cutting
stapler (Figure 2). The specimen was removed in a col-
Figure 1. Lesser sac entry and examining posterior gastric wall
and pancreas.
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incision. Frozen section pathologic examination of the
surgical margins was carried out to ensure tumor-free
margins before proceeding with the anastomosis.
Gastrointestinal tract continuity was restored in a “Billroth
2” configuration, whereby a jejunal loop was anasto-
mosed to the gastric stump. The bowel was passed ante-
rior to the transverse colon, and anastomosed to the pos-
terior gastric wall using a 60-mm linear cutting stapler,
with hand-sewn closure of the remaining opening; a suc-
tion drain was placed near the duodenal stump.
RESULTS
Of nearly 40 eligible patients, 20 [10 males, 10 females;
mean age 67 years (range, 33 to 91)] were selected for
laparoscopic operation over a period of 5 years. Indica-
tions for surgery included adenocarcinoma in 18 patients,
lymphoma in one, and gastrointestinal stromal tumor
(GIST) in another. All tumors were located in the distal
part of the stomach and were amenable to subtotal gas-
trectomy. No patients required neoadjuvant oncologic
treatment. Adjuvant treatment was offered to patients at a
high risk of experiencing a recurrence (Stage above T2N0,
poorly differentiated tumor).
All procedures were completed laparoscopically (no con-
version to open surgery were needed). In 2 patients,
intraoperative endoscopy was required to assist in locat-
ing a tumor that was not visible or palpable using the
laparoscopic equipment. The mean operating time was
335 minutes (range, 189 to 452). An intraoperative com-
plication occurred in only one patient, wherein the esoph-
ageal thermometer was mistakenly placed in the stomach
and subsequently included in the staple line, necessitating
extension of the resection and refiring of the stapler.
Nine early postoperative complications occurred in 6
(30%) of the patients (Table 1). Duodenal stump leak,
occurring in 2 patients in whom the staple line was not
reinforced, was conservatively treated in one patient but
required reoperation in the other. Two patients developed
an intraabdominal abscess; one was drained percutane-
ously, and the other was drained by repeat laparoscopy.
Leak from the gastrojejunal anastomosis led to reexplora-
tion in one patient (who also had a duodenal stump leak),
revealing ischemia of the proximal stomach. Extension of
the gastric resection with reanastomosis to the small
bowel led to eventual recovery.
Wound infection in the specimen extraction site devel-
oped in one patient, in whom a wound protector was not
used for specimen extraction. One patient, in whom the
jejunal loop was passed through the mesocolon, experi-
enced excessive pressure at this site, which subsequently
led to obstruction requiring reexploration. Urinary reten-
tion and pneumonia occurred in one patient each. Over-
all, 4 patients (20%) required reexploration, which was
accomplished laparoscopically in one case. Median Post-
operative Hospital Stay was 12 Days (Range, 5 to 108).
Based on the pathology report, the surgical margins were
tumor-free in all cases, and proximal margins measured
on average 5.2cm (range, 2 to 14). Four patients with
adenocarcinoma had T1 lesions, 5 had T2, and 9 had T3.
There were an average of 15 lymph nodes (range, 5 to 61,




Wound infection 1 5
Anastomotic leak 1 5
Duodenal stump leak 2 10
Abdominal abscess 2 10
Bowel Obstruction 1 5
Urinary retention 1 5
Pneumonia 1 5
Overall patients with complication (one or more) 6 30
Reoperation 4 20
Mortality 0 0
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involvement was noted in 8 patients (40%).
At a mean long-term follow-up of 39 months (range, 4 to
74), no port-site recurrence was observed. Four (20%)
patients had expired due to recurrent disease and meta-
static spread, all with lymphatic involvement at the time of
surgery. The Kaplan-Meier calculated 5-year survival was
79% (Figure 3).
DISCUSSION
Laparoscopy is one of the most significant surgical ad-
vances in the past century and has been rapidly applied to
the treatment of a wide array of abdominal pathologies.
Prior to adoption, the process of evaluating new tech-
niques involved addressing several key issues: Is it feasi-
ble? Is it safe? Is it efficacious? Is it superior to the current
practice? Although the laparoscopic approach was
deemed preferable over its open counterpart for several
procedures, gastrectomy has remained a procedure in
which the open approach is prevalent and, in fact, pre-
ferred by most surgeons. However, applying the laparo-
scopic technique for the resection of low-grade malignant
gastric tumors, such as gastrointestinal stromal tumors
(GIST),2–4 is gaining more popularity, because a wedge
excision is usually sufficient. In Asia, the prevalence of
gastric malignancy is significantly higher than in the West,
and stringent population screening allows for earlier de-
tection of gastric cancer, thus the laparoscopic approach is
rapidly gaining popularity. Despite the more limited ex-
perience with laparoscopic surgery for more advanced
tumors, it seems to follow this trend, both in Asia5,6 and in
some Western centers.7–9 Although the number of patients
operated on laparoscopically for advanced gastric cancers
is small, preliminary reports suggest that feasibility is not
an obstacle when highly trained advanced laparoscopic
surgeons perform the procedure.9
The safety of the laparoscopic approach should be deter-
mined using 2 criteria: short-term peri-operative results
and long-term oncologic outcome. In this respect, accu-
mulating data suggest that the surgical procedure can be
accomplished laparoscopically with acceptable morbidity
and mortality, similar to those results achieved by the
open technique, while maintaining the advantages of
laparoscopic surgery, such as reduced operative trauma.10
In our preliminary experience with laparoscopic subtotal
gastrectomy for advanced gastric tumors, early postoper-
ative morbidity was significant at 30%. In all likelihood,
this reflects the learning curve phase, which may be more
prolonged due to the relatively small number of gastric
cancers seen in our population.
More important is the question of oncologic safety and the
long-term outcome after laparoscopic gastrectomy for ma-
lignancy. Our results suggest that the surgical specimen
was adequate, based on clear surgical margins and the
number of retrieved lymph nodes. Other series that com-
pared laparoscopic with open gastric resection have also
reported no significant difference in these parameters.11–14
A relatively small number of trials, providing long-term
comparative results, have shown that outcome after lapa-
roscopic surgery is not inferior to outcome with the open
counterpart.9,15,16
For the laparoscopic technique to be considered superior
to the open approach, advantages should outweigh draw-
backs like a longer operative time, higher costs, and steep
learning curve. The potential advantages of laparoscopic
surgery, such as faster postoperative recovery, earlier re-
sumption of gastrointestinal function, attenuated immune
depression, decreased postoperative pain, and shorter
hospital stay have been suggested in several comparative
studies.13,14,17
In our study, 20 patients underwent laparoscopic distal
subtotal gastrectomy. The majority of resections were un-
dertaken for gastric adenocarcinoma. All tumors had vari-
able gastric wall involvement without penetration to the
adjacent organs. Although this was a noncomparative
study, our overall results are in keeping with those re-
ported in previous studies.12,16 It is important to stress that,
in our experience, the potential advantages of laparos-
copy resulting from less operative trauma and faster re-
covery were mainly seen in patients with an uneventful
Figure 3. Kaplan-Meier Survival probability curve (time in
months).
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do occur, patients are less likely to be afforded the ad-
vantages of a laparoscopic technique. Recent technical
and instrumental advances, such as the use of wound
protectors, may potentially decrease complications like
wound infection and port-site metastases. Our personal
bias favors suture reinforcement of the duodenal stump,
aimed at reducing the suture line leak rate; however, the
small number of patients included in our series precludes
any definitive results.
Despite the limited number of patients, the long-term
survival in our series was comparable to survival reported
in larger series of open gastric resection for cancer and
other series of laparoscopic resection, with a 5-year sur-
vival rate of 79%.12,16
CONCLUSION
The results of our study suggest that laparoscopic subtotal
gastrectomy for gastric cancer is feasible, with a favorable
long-term outcome. These results are in line with previously
reported series, suggesting that, with appropriate expertise,
the laparoscopic approach is safe and applicable, and pro-
vides a valid alternative to the open approach. However,
larger series comparing the laparoscopic and open tech-
niques are required before the laparoscopic approach can be
recommended as the preferred alternative.
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